Pages

Saturday, January 21, 2012

BMI May Be Flawed Measure Of Health.

The Boston Globe Share to FacebookShare to Twitter (1/7, Kotz) discussed why body mass index (BMI) may be a limited measure of health, since "some people's weight and height measurements put them in the overweight or even obese category while, in reality, they are very lean and muscular. On the other hand, some people's BMI indicates that they are healthy, when they are actually overfat, with little lean tissue. So, whether or not your BMI indicates that you are overweight, it is important to find out if you are carrying too much body fat." Some experts believe "it's worthwhile to have a body composition test once a year."

Group Issues Guideline For Hyperglycemia Management In Hospital Patients.

MedPage Today Share to FacebookShare to Twitter (1/6, Neal) reports, "All hospital patients should have blood glucose levels measured on admission, according to an Endocrine Society clinical practice guideline Share to FacebookShare to Twitter on managing hyperglycemia in non-critically ill patients" to appear in the Journal of Clinical Endocrinology & Metabolism. "For most patients with type 2 diabetes, the authors suggest discontinuation of oral hypoglycemic agents and initiation of insulin therapy on admission for an acute illness." This recommendation "applies to both diabetic and normoglycemic patients, and goes one step further than guidance from the American Diabetes Association (ADA)," which "has recommended initial glucose measurements for diabetic patients and nondiabetic patients who are receiving therapies associated with hyperglycemia, with the recognition that high blood glucose has been associated with a greater risk for complications and death among hospitalized patients."

Hemodialysis Using Solar Power May Reduce Costs, Help Save Environment.

CBC News Share to FacebookShare to Twitter (1/6) reports that according to a study to appear Jan. 19 in the Clinical Journal of the American Society of Nephrology, "using solar power can make" hemodialysis "treatments more environmentally friendly." For the study, "scientists created a solar-assisted dialysis program in southern Australia. They set up four dialysis machines that ran partially off solar power." Notably, "the program reduced power costs by 76.5 per cent in the first 12 months."

Increased Gout Risk With Diuretic Use Confirmed

       By Nancy Walsh, Staff Writer, MedPage Today
Published: January 05, 2012
Reviewed by Zalman S. Agus, MD; Emeritus Professor
University of Pennsylvania School of Medicine and
Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner

Action Points  
  • Use of diuretics has been shown to be associated with gout, but many of the studies were in patients being treated for hypertension and it is conceivable that the underlying hypertension may itself have contributed to the association with gout.


  • This study indicates that thiazide and loop diuretics are associated with an increased risk of gout which appears to be mediated by an increase in serum urate levels.
Diuretics -- a class of drugs known to raise serum urate levels -- independently increased the risk for gout in patients with high blood pressure, a prospective cohort study revealed.
After adjustment for blood pressure and potential confounders such as glomerular filtration rate, exposure to a diuretic led to a 1.48-fold increased likelihood of incident gout (95% CI 1.11 to 1.98), according to Mara A. McAdams DeMarco, PhD, of Johns Hopkins University in Baltimore, and colleagues.
However, further adjustment for the level of serum urate nullified this association (HR 0.96, 95% CI 0.71 to 1.28), "suggesting that serum urate level may be a key intermediate on the pathway between diuretic use and incident gout," the researchers wrote in the January issue of Arthritis & Rheumatism.
A possible link between diuretic use and gout was identified more than 25 years ago, but it has remained unclear whether the diuretic or the underlying hypertension is the main culprit.
So DeMarco and colleagues analyzed data from the population-based Atherosclerosis Risk in Communities studies, focusing on 5,789 participants with hypertension, but not gout, at baseline.
Men represented 42% of the cohort and African-Americans 31%. Mean age at the time of enrollment was 55, and mean body mass index was 29.
A total of 37% of participants used diuretics during nine years of follow-up.
The cumulative incidence of gout overall was 3.9%, but was higher in men than in women (5.3% versus 2.8%).
The cumulative incidence of gout was significantly higher among those taking diuretics than among those not taking the drugs (5.5% versus 2.9%, P<0.001), the researchers reported.
Any diuretic use also was associated with a three-fold higher risk of gout compared with untreated hypertension (HR 3.35, 95% CI 2.49 to 4.51).
The risk of gout was elevated with both thiazide (HR 1.44, 95% CI 1 to 2.10) and loop (HR 2.31, 95% CI 1.36 to 3.91) diuretics, they noted.
A total of 63 patients on thiazide diuretics developed gout, which represented a cumulative incidence of 5%; 23 cases occurred with loop diuretics, for an incidence of 7%.
However, once again the association was lost after adjustment for serum urate levels for both thiazide (HR 0.94, 95% CI 0.64 to 1.38) and loop (HR 1.35, 95% CI 0.78 to 2.34) diuretics.
In contrast to diuretics, treatment with other types of antihypertensive decreased the risk of gout (HR 0.64, 95% CI 0.49 to 0.86), and the risk was unchanged after adjustment for urate levels.
Among patients who began diuretic treatment after enrollment in the study, serum urate levels were 0.72 mg/dL higher than in patients not taking the drugs, while initiation of a nondiuretic antihypertensive led to a decrease of 0.21 mg/dL.
"Future studies should not only confirm the risk of gout associated with diuretic-induced hyperuricemia but also further elucidate the complicated relationship of hypertension, diuretics, uric acid, and gout," DeMarco and colleagues stated.
Limitations of the study included self-report of gout, possible selection bias or confounding by indication, and a lack of information on specific brands of medication.
This work was supported by the National Institutes of Health, the Donald B. and Dorothy Stabler Foundation, and the Ira T. Fine Discovery Fund. The authors reported no relationships with industry.

WSJournal Column Reviews New Wireless Glucometer.

On the front of its Personal Journal section, the Wall Street Journal Share to FacebookShare to Twitter (1/5, D1, Mossberg, Subscription Publication) reviews in its "Personal Technology" column a new wireless glucometer for patients with diabetes. Called the Telcare meter, the new device will not only measure blood sugar, but will also transmit the readings to an accessible database that can be read by patients, physicians and family members. The device defaults to the T-Mobile network, but will shift automatically to other networks if T-Mobile is not available. Drawbacks are high price, poor battery life, and user inability to get test strips or the meter itself from pharmacies. Instead, patients must buy the meter and its supplies directly from Telcare.

FDA Announces Restrictions On Cephalosporin Use In Farm Animals.

The New York Times Share to FacebookShare to Twitter (1/5, A12, Harris, Subscription Publication) reports that the FDA "announced on Wednesday that farmers and ranchers must restrict their use of a critical class of antibiotics," cephalosporins, "in cattle, pigs, chickens and turkeys because such practices may have contributed to the growing threat in people of bacterial infections that are resistant to treatment." The medicines "are among the most common antibiotics prescribed to treat pneumonia, strep throat, and skin and urinary tract infections." Michael R. Taylor, deputy commissioner for foods at the FDA, said, "We believe this is an imperative step in preserving the effectiveness of this class of important antimicrobials that takes into account the need to protect the health of both humans and animals."
        The AP Share to FacebookShare to Twitter (1/5, Jalonick) reports, "In a statement Share to FacebookShare to Twitter on the FDA website, the agency said the announcement is 'among a number of ongoing FDA activities and initiatives intended to address concerns about the use of antimicrobial drugs in animal agriculture.'" These "include increased monitoring and voluntary guidelines for producers on how to use the drugs judiciously."
        The Wall Street Journal Share to FacebookShare to Twitter (1/5, Tomson, Subscription Publication) reports the FDA said that in 2010, US farm animals were given roughly 54,000 pounds of cephalosporins, although altogether, the animals consumed more than 29 million pounds of antibiotics.
        The Washington Post Share to FacebookShare to Twitter (1/5, Elboghdady) reports, "The antibiotics can no longer be used to prevent diseases in livestock starting April 5, though they can still be used to treat illnesses, the FDA said." Although "consumer advocates support the FDA's decision," they contend that "the move is long overdue and deals with only one small part of a much larger public health issue tied to the overuse of antibiotics in animals."
        The Chicago Tribune Share to FacebookShare to Twitter (1/5, Eng) reports that US Rep. Louise Slaughter (D-NY) said, "This is a modest first step by the FDA," although "we're really just looking at the tip of the iceberg. We don't have time for the FDA to ploddingly take half-measures." According to Slaughter, "We are staring at a massive public health threat in the rise of antibiotic-resistant superbugs."
        The Los Angeles Times Share to FacebookShare to Twitter (1/5, Brown) "Booster Shots" blog reports that Slaughter also said, "With over 1 million Salmonella cases in the US each year, at least 30,000 Americans will contract cephalosporin-resistant bacteria every year. I'm glad the FDA is finally acting but how many Americans have needlessly been sickened in the meantime?"
        CQ Share to FacebookShare to Twitter (1/5, Ethridge, Subscription Publication) reports, "American Academy of Pediatrics President Robert Block also praised the decision, noting that cephalosporin drugs are often used to treat several serious childhood infections and have no warnings for pediatric use." According to Block, "Pediatricians are already limited in the number and types of antibiotics that we can use to treat ill children, and when one type of antibiotic is found to be resistant to a strain of an infection, some of our sickest young patients are left without life-saving treatment options."
        The National Journal Share to FacebookShare to Twitter (1/5, Fox, Subscription Publication) reports, "The comment period on the new order closes on March 6." The agency "first proposed the rule in 2008 and has been tweaking it ever since because of objections from a range of groups."
        Also covering the story are Bloomberg News Share to FacebookShare to Twitter (1/5, Peterson, Armour), the Lincoln (NE) Journal Star Share to FacebookShare to Twitter (1/5, Hovey), Reuters Share to FacebookShare to Twitter (1/5, Yukhananov), HealthDay Share to FacebookShare to Twitter (1/5, Preidt), and MedPage Today Share to FacebookShare to Twitter (1/5, Walker).

DASH Diet Ranked No. 1 By US News & World Report.

The Los Angeles Times Share to FacebookShare to Twitter (1/4, Stein) reported that the Dietary Approaches to Stop Hypertension (DASH) "diet took the No. 1 spot in best overall diet in the US News & World Report's Best Diets 2012, which also rates other popular diets in various categories." The DASH diet "also took top ranking as the best diet for healthy eating and the best diabetes diet (tied with the Biggest Loser diet)." In addition, the DASH diet "may also help lower cholesterol, as it's big on whole grains, fruits, vegetables and lean proteins -- not a bad program for a number of people."
        NIH Diet Ranked 2nd Best Overall By US World & News Report. WebMD Share to FacebookShare to Twitter (1/5, Doheny) reports that "the US News & World Report's Best Diets 2012, a rating of 25 different diet plans," rated "Therapeutic Lifestyle Changes (TLC), a diet that's high in fiber and low in fat, developed by the National Institutes of Health," in second place "in the best diets overall category." The ratings Share to FacebookShare to Twitter may be viewed online. 

More on the DASH Diet: